glp1 vs semaglutide Tirzepatide vs. Semaglutide: What You Should Know Liraglutide vs Semaglutide vs GLP-1

Gustafsson H, Sderdahl T, Jnsson G, Bratteng JO, Forsby A

PMID: 32026278

Phase II conjugation reactions add large polar groups to phase I metabolites or active drug to enhance water solubility and excretion

Reported protocols from research settings and case literature include: Subcutaneous self-injection at doses of 0.5-1 mg Loading phase protocols followed by maintenance dosing Typical research doses of 0.025 mg/kg in clinical studies No standardized reconstitution or storage protocols in unregulated use The self-administration model and lack of pharmaceutical-grade products create additional safety risks absent from the Melanotan-1 paradigm